Edgewise Therapeutics, Inc.
EWTX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $46 | $43 | $50 | $42 |
| Short-Term Investments | $517 | $551 | $386 | $429 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $11 | $9 | $7 | $5 |
| Total Curr. Assets | $574 | $603 | $443 | $475 |
| Property Plant & Equip (Net) | $10 | $10 | $11 | $11 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $1 | $0 |
| Total NC Assets | $10 | $10 | $11 | $11 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $583 | $613 | $454 | $487 |
| Liabilities | – | – | – | – |
| Payables | $6 | $8 | $9 | $6 |
| Short-Term Debt | $1 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $14 | $6 | $4 | $10 |
| Total Curr. Liab. | $22 | $21 | $21 | $24 |
| LT Debt | $3 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $3 | $3 | $4 | $4 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $4 | $4 | $5 | $5 |
| Total Liabilities | $25 | $24 | $25 | $28 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$496 | -$455 | -$419 | -$379 |
| AOCI | $1 | $0 | $0 | $0 |
| Other Equity | $1,054 | $0 | $0 | $0 |
| Total Equity | $559 | $589 | $430 | $459 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $583 | $613 | $454 | $487 |
| Net Debt | -$42 | -$43 | -$50 | -$42 |